Why Choose AVITI for Mid-Throughput Sequencing?

Medium levels of sequencing information, between 1-50 Gb during a singular use, can be produced through mid-throughput sequencing. As a result, it can be used for targeted sequencing, where the functions of a genome or genes can be considered instead of looking at the full genome or RNA-seq, also known as transcriptome profiling, where molecules of RNA can be sequenced to learn about the patterns of gene expressions.

The capabilities of mid-throughput sequencing make it extremely useful. With its extensive read range and relatively high-throughput, it is adaptable and can be applied to specific studies within genomics, from considering genes and how they connect to different diseases to uncovering the genetics of various populations.

For optimal mid-throughput sequencing results, the right tools and technologies are required. Enter the AVITI sequencing system. Created by Element Biosciences, AVITI can enhance the quality of information, having achieved a Q40 quality score at 85.4% with its bases. This is only one of the advantages of Elemental Biosciences’ AVITI system. Join us as we consider more of the benefits of AVITI and why it should be utilized for mid-throughput sequencing.

Superior Quality and Cost-Effectiveness

A key differentiator for the AVITI sequencer is its unique “sequencing-by-binding” chemistry. It has been shown to deliver exceptional accuracy. Studies and operational data suggest that over 90% of bases sequenced using AVITI achieve a Phred quality score exceeding 30 – a benchmark of high-quality sequencing data. This level of accuracy is paramount for applications requiring reliable variant detection and precise genomic analyses.

Moreover, the AVITI sequencer accomplishes this high quality at a significantly lower cost compared to traditional options like Illumina sequencers. On average, the cost per Gb of sequencing data ranges between $2 and $5. This makes it an economically viable option for sequencing projects. This disruptive pricing model does not compromise on output quality. Ultimately, AVITI is an attractive choice for labs seeking to maximize their budget efficiency while maintaining high data standards.

Flexibility and Ease of Use

Designed with the user experience in mind, the AVITI sequencer boasts:

  • Guided workflows
  • Comprehensive run parameters
  • Flexible system settings.

These features make it accessible to laboratories of all sizes and levels of sequencing experience. Its “plug-and-run” benchtop design simplifies operational processes, allowing for straightforward implementation in diverse research settings.

The convenience of AVITI extends to its compatibility with standard Illumina library preparation kits. This interoperability facilitates seamless integration into existing sequencing workflows, reducing the need for additional training or significant adjustments to laboratory protocols.

Disruptive Pricing Model

The AVITI sequencer’s cost per Gb is not only competitive but disruptive. It challenges the pricing models of established sequencing technologies. This affordability, combined with a reagent price guarantee, ensures long-term budget predictability for laboratories. Such economic considerations are crucial for mid-throughput labs. In these labs, the balance between cost and throughput is often a determining factor in technology adoption.

The AVITI sequencer by Element Biosciences represents a significant advancement in mid-throughput sequencing. It addresses both the technical and operational challenges faced by modern laboratories. AVITI makes a compelling option for a broad spectrum of genomic research and clinical applications through its combination of:

  • High-quality sequencing data
  • Cost-efficiency
  • Ease of use
  • Seamless workflow integration.

By offering these advantages within a disruptive pricing framework, AVITI is well-positioned to become a top consideration for routine research.

The Role of AVITI at Source Genomics

At Source Genomics, a part of Source BioScience, we understand the critical role that cutting-edge genomic sequencing technology plays in advancing scientific research and clinical diagnostics. The AVITI System by Element Biosciences represents a leap forward in our mission to provide our clients with the most effective solutions.

Integrating the AVITI System into our portfolio, we are not just offering another sequencing service. Instead we are providing a gateway to the future of genomic sequencing. It underscores our promise to deliver seamless and efficient solutions to our clients, through its:

  • Ease of use
  • Compatibility with existing workflows
  • Comprehensive data analysis capabilities.

As we embrace this next generation of sequencing technology, we are excited about the possibilities it unlocks for genomic research and diagnostics. The AVITI System is more than a tool; it is a partner in discovery, enabling our clients to explore the complexities of the genome with unprecedented precision and affordability.

Utilise the Capabilities of AVITI for Mid-Throughput Sequencing

AVITI technology stands as a symbol of innovation for mid-throughput sequencing. By using a flow cell, it can create about a billion reads and also establish two separate libraries. With its utility and extensive abilities, it is not surprising that it has the potential to enhance your work surrounding genomics, as well as how you undertake mid-throughput sequencing analysis.

However, we understand that a capital equipment investment has to be carefully considered and is not always possible or indeed necessary, providing researchers have access to these technologies in other ways such as through reliable and trusted sequencing partners like Source. If you are ready to try AVITI, please reach out to Source Bioscience for an introductory conversation. Simplify your sequencing analysis through the power of AVITI and our knowledge of next-generation sequencing.

Contact us today and one of our skilled account managers will be in touch with a free consultation including further information and pricing details.

Share this article